Literature DB >> 10569199

Receptor-Ck regulates the expression of cyclin-dependent kinase inhibitors (p16; p27).

D Kaul1, M Kaur.   

Abstract

The present study was addressed to understand the interrelationship between Receptor-Ck induction-activation coupling; isoprenoids (derived from mevalonate pathway) and cyclin-dependent kinase inhibitors. The results reported here unambiguously reveal that isoprenoids regulate the expression of genes coding for CDK inhibited p16 and p27. Further, Receptor-Ck dependent signalling, known to control the mevalonate pathway, had a direct effect upon the p27 gene expression. Based upon these studies coupled with our earlier findings we propose that Receptor-Ck has an important role in the regulation of cell cycle machinery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569199     DOI: 10.1023/a:1006981614054

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  13 in total

Review 1.  Receptor-Ck and leukemogenesis.

Authors:  D Kaul
Journal:  Leuk Res       Date:  1998-05       Impact factor: 3.156

Review 2.  Cell cycle control of DNA replication.

Authors:  B Stillman
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

3.  Mevalonate deprivation alters the induction of fos and myc by growth factors.

Authors:  V Barbu; F Dautry
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

4.  LDL-dependent regulation of Bcl-2 and cyclin 'D' gene expression in lymphocytes from normal and CML patients.

Authors:  D Kaul; M Kaur
Journal:  Cancer Lett       Date:  1997-11-11       Impact factor: 8.679

5.  Does receptor-'Ck' deficiency initiate leukaemia?

Authors:  D Kaul; J Singh
Journal:  Cancer Lett       Date:  1997-01-30       Impact factor: 8.679

6.  Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein.

Authors:  D S Peeper; T M Upton; M H Ladha; E Neuman; J Zalvide; R Bernards; J A DeCaprio; M E Ewen
Journal:  Nature       Date:  1997-03-13       Impact factor: 49.962

7.  Molecular mechanism involved in TPA-induced myelopoietic programming.

Authors:  D Kaul; N Varma
Journal:  Leuk Res       Date:  1999-03       Impact factor: 3.156

8.  Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation.

Authors:  S Vitols; G Gahrton; A Ost; C Peterson
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

9.  Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.

Authors:  G P Linette; Y Li; K Roth; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

Authors:  S N Khleif; J DeGregori; C L Yee; G A Otterson; F J Kaye; J R Nevins; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more
  5 in total

Review 1.  Molecular link between cholesterol, cytokines and atherosclerosis.

Authors:  D Kaul
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Receptor-Ck regulates giardia encystation process.

Authors:  D Kaul; R Rani; R Sehgal
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

3.  Receptor-Ck regulates membrane-bound 125 kDa protein having affinity for genomic sterol regulatory sequence.

Authors:  D Kaul; M Kaur
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

Review 4.  Role of cholesterol in parasitic infections.

Authors:  Devendra Bansal; Harinderpal Singh Bhatti; Rakesh Sehgal
Journal:  Lipids Health Dis       Date:  2005-05-09       Impact factor: 3.876

5.  Lipid profile in oral submucous fibrosis.

Authors:  Ravi Mehrotra; Shruti Pandya; Ajay Kumar Chaudhary; Himanshu Pratap Singh; Ritesh Kumar Jaiswal; Mangal Singh; S C Gupta; Mamta Singh
Journal:  Lipids Health Dis       Date:  2009-07-24       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.